Arrowhead Pharmaceuticals | search
Click here to view Arrowhead Pharmaceuticals news from 60+ newspapers.
Bookmark or Share- Our Pipeline | Arrowhead PharmaceuticalsScience & Innovation. We’re relentless in our pursuit of altering the course of diseases. Discover Our Science. Check out the development of Arrowhead’s products to treat challenging cardiometabolic, pulmonary, neuromuscular, liver, and more types of diseases.
- About Us | Arrowhead PharmaceuticalsLearn more about Arrowhead Pharmaceutical's foundation as a therapeutic discovery company, innovative use of RNAi, and ambitious pipeline for developing medicines.
- Arrowhead Pharmaceuticals - WikipediaRevenue. $243.2 million (2022) [1] Number of employees. 376. Website. arrowheadpharma .com. Arrowhead Pharmaceuticals is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference (RNAi) mechanisms of action.
- Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for ...Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today that it has dosed the first subjects in a Phase 1/2a clinical trial (NCT06209177) of ARO-CFB, the company’s investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and patients with complement mediated kidney disease.
- Arrowhead Pharmaceuticals Earns $50 Million Milestone from ... - BioSpaceAbout Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes.
More
